Please cite this article as: Bonanad C, Fernández-Olmo R, García-Blas S, Alarcon JA, Díez-Villanueva P, Mansilla CR, García-Pardo H, Toledo P, Ayesta A, Pereira E, Carol A, Castro-Conde A, de Pablo-Zarzoso C, Martínez-Sellés M, Arrarte V, Campuzano R, Ariza-Solé A. Cardiovascular prevention in elderly patients. J Geriatr Cardiol 2022; 19(5): 377−392. DOI: 10.11909/j.issn.1671-5411.2022.05.004.
Citation: Please cite this article as: Bonanad C, Fernández-Olmo R, García-Blas S, Alarcon JA, Díez-Villanueva P, Mansilla CR, García-Pardo H, Toledo P, Ayesta A, Pereira E, Carol A, Castro-Conde A, de Pablo-Zarzoso C, Martínez-Sellés M, Arrarte V, Campuzano R, Ariza-Solé A. Cardiovascular prevention in elderly patients. J Geriatr Cardiol 2022; 19(5): 377−392. DOI: 10.11909/j.issn.1671-5411.2022.05.004.
shu
    Abstract
  • In recent decades, life expectancy has been increasing significantly. In this scenario, health interventions are necessary to improve prognosis and quality of life of elderly with cardiovascular risk factors and cardiovascular disease. However, the number of elderly patients included in clinical trials is low, thus current clinical practice guidelines do not include specific recommendations. This document aims to review prevention recommendations focused in patients ≥ 75 years with high or very high cardiovascular risk, regarding objectives, medical treatment options and also including physical exercise and their inclusion in cardiac rehabilitation programs. Also, we will show why geriatric syndromes such as frailty, dependence, cognitive impairment, and nutritional status, as well as comorbidities, ought to be considered in this population regarding their important prognostic impact.
    • FullText(HTML)
  • loading
    • References (109)
    • Relative Articles
  • Supplements (0)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return